Loading cancer entity…
Loading cancer entity…
Clinical trials
231 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03439085 | DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers | terminated | Phase 2 | 41 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT05578820 | Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid | completed | Phase 1 | 21 | Gene Surgery LLCINDUSTRY | 1 | Jul 1, 2024 | clinicaltrials |
| NCT04422366 | Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | recruiting | Phase 3 | 8,000 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Jun 7, 2024 | clinicaltrials |
| NCT04269837 | Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer | completed | N/A | 4 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT04895020 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | unknown | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05905315 | Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC(VULCANIZE-II) | recruiting | Phase 2 | 98 | The Netherlands Cancer InstituteOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT03285841 | OCT-AF Imaging of Pre-cancers of Vulva and Cervix | terminated | — | 20 | British Columbia Cancer AgencyOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT03051516 | HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions | terminated | Phase 4 | 188 | Fred Hutchinson Cancer CenterOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06273501 | MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer(POSVUC) | unknown | N/A | 20 | Sahlgrenska University HospitalOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT05787535 | HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor | unknown | Phase 1 | 17 | HRYZ Biotech Co.INDUSTRY | 1 | Feb 2, 2024 | clinicaltrials |
| NCT05952947 | HRYZ-T101 Injection for HPV18 Positive Solid Tumor | recruiting | Phase 1 | 32 | HRYZ Biotech Co.INDUSTRY | 1 | Feb 2, 2024 | clinicaltrials |
| NCT06202339 | Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT). | not yet recruiting | N/A | 10 | Alpha Tau Medical LTD.INDUSTRY | 0 | Jan 31, 2024 | clinicaltrials |
| NCT02735109 | Interest of the Confocal Microscope in the Diagnosis of Epidermoid Carcinoma of the Vulva and Their Precursors | terminated | N/A | 10 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT05916690 | Electrochemotherapy for the Treatment of Vulvar Cancer | unknown | N/A | 20 | Institute of Oncology LjubljanaOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT06161428 | Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer(SENTIVUC II) | recruiting | — | 100 | Rigshospitalet, DenmarkOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT06029504 | Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I)(SENTIVUC) | recruiting | — | 115 | Rigshospitalet, DenmarkOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT05372016 | Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Nov 24, 2023 | clinicaltrials |
| NCT02875561 | Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia | completed | N/A | 47 | University of Colorado, DenverOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06132321 | Quality of Life in Patients Undergone Vulvar Reconstruction After Vulvar Cancer Resection (3233) | unknown | — | 93 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Nov 15, 2023 | clinicaltrials |
| NCT04147780 | Sentinel Node Extended in Squamous Cell Vulvar Cancer(SNEX) | completed | — | 64 | Diana ZachOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT04152512 | Quality of Life, Unmet Needs and Satisfaction With Care After Vulvar Cancer(PROVE) | active not recruiting | — | 153 | Karolinska University HospitalOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT03452332 | Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers | completed | Phase 1 | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT03180684 | Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) | completed | Phase 2 | 33 | Inovio PharmaceuticalsINDUSTRY | 1 | Aug 25, 2023 | clinicaltrials |
| NCT06007625 | Vulvar Cancer Individualized Scoring System (VCISS) | unknown | — | 1,000 | Assiut UniversityOTHER | 1 | Aug 23, 2023 | clinicaltrials |
| NCT04066894 | Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study | terminated | Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05076942 | Groningen International Study on Sentinel Nodes in Vulvar Cancer-III(GROINSS-VIII) | recruiting | Phase 2 | 157 | University Medical Center GroningenOTHER | 2 | Aug 1, 2023 | clinicaltrials |
| NCT03339765 | Self-Advocacy Serious Game in Advanced Cancer | completed | N/A | 78 | University of PittsburghOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT04952961 | Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study | completed | N/A | 25 | University of ManchesterOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT04761146 | A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer(DaRT-V) | unknown | N/A | 10 | CCTU- Cancer ThemeOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05853549 | Clinical Implementation of Surface-guided Radiation Therapy in Vulvar Cancer | completed | N/A | 10 | Peking Union Medical College HospitalOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT03695809 | The Association of G9a Protein and Clinical Outcome of Patients With Vulvar Cancer | unknown | — | 30 | Far Eastern Memorial HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT01399658 | Image-Guided Gynecologic Brachytherapy(AMIGO) | completed | Phase 2 | 93 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05761132 | Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept Study(Apollo) | unknown | Phase 2 | 40 | Leiden University Medical CenterOTHER | 0 | Mar 9, 2023 | clinicaltrials |
| NCT04704908 | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | unknown | — | 979 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04969445 | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 647 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05045755 | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 1,339 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT03517488 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors(DUET-2) | completed | Phase 1 | 150 | Xencor, Inc.INDUSTRY | 1 | Dec 1, 2022 | clinicaltrials |
| NCT05580341 | Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 | unknown | Phase 3 | 1,200 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 1 | Oct 28, 2022 | clinicaltrials |
| NCT04161664 | Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy(CRAVAT) | recruiting | Phase 2 | 12 | The Netherlands Cancer InstituteOTHER | 1 | Oct 19, 2022 | clinicaltrials |
| NCT00943722 | A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) | completed | Phase 3 | 3,074 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Oct 3, 2022 | clinicaltrials |
| NCT05561413 | Gynaecology Exercise and Mindfulness Study(GEMS) | unknown | N/A | 40 | University of UlsterOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT05536843 | Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests(TTMV HPV DNA) | unknown | — | 500 | University of Mississippi Medical CenterOTHER | 0 | Sep 13, 2022 | clinicaltrials |
| NCT05426148 | Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female | completed | Phase 4 | 540 | Xiamen Innovax Biotech Co., LtdINDUSTRY | 1 | Jun 29, 2022 | clinicaltrials |
| NCT05395962 | Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer(Elechtra) | recruiting | Phase 2 | 92 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT03372720 | Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors | completed | N/A | 19 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT02067052 | New Strategy for the Treatment of Vulvar Cancer | unknown | — | 44 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 15, 2022 | clinicaltrials |
| NCT04425291 | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,680 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Feb 25, 2022 | clinicaltrials |
| NCT03221400 | PEN-866 in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 340 | Tarveda TherapeuticsINDUSTRY | 1 | Feb 17, 2022 | clinicaltrials |
| NCT05242861 | Retrospective Study of Brachytherapy(RetroBT) | recruiting | — | 300 | Zhejiang Cancer HospitalOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT01595061 | Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva | unknown | Phase 2 | 57 | Gynecologic Oncology GroupNETWORK | 1 | Dec 29, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Jul 9, 2024source: clinicaltrials